Skin Diseases, Infectious Completed Phase 3 Trials for Ceftobiprole medocaril (DB14733)

Also known as: Infectious Skin Disease / Infectious Skin Diseases / Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00210899Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsTreatment
NCT00228982Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsTreatment